NAGE vs NTRS · P/E 59, rev $61.3M vs P/E 18, rev $2.69B
Niagen Bioscience, Inc. (NAGE) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the NAGE and NTRS stock pages for the full models.
Not investment advice.